| Abstract | Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis. |
| Authors | David R Adams, Tamy Buckel, Jennifer A Sceppa
(Affiliation: Penn State Hershey Medical Center, Department of Dermatology, Hershey, PA 17033, USA. dadams at psu.edu)
|
| Journal | Journal of drugs in dermatology : JDD
(J Drugs Dermatol)
Vol. 5
Issue 2
Pg. 178-9
(Feb 2006)
ISSN: 1545-9616 United States |
| PMID | 16485887
(Publication Type: Case Reports, Journal Article)
|
| Chemical References |
- Antibodies, Monoclonal
- Dermatologic Agents
- infliximab
|
| Topics |
- Adult
- Antibodies, Monoclonal
(adverse effects)
- Dermatologic Agents
(adverse effects)
- Humans
- Inflammatory Bowel Diseases
(drug therapy)
- Male
- Psoriasis
(chemically induced)
|
